Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
What Are the Key Projections for the CAGR of the Cholestatic Pruritus Market Size From 2025 to 2034?
The market size for cholestatic pruritus has seen a robust growth in the recent past. The projections suggest it will escalate from $19.20 billion in 2024 to $20.28 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.6%. This significant growth observed in the historic period is a result of various factors such as an increase in skin-related health problems, significant investment in research and development, the need for efficient treatment approaches, a heightened understanding of the condition, and beneficial regulatory conditions.
Over the next few years, the market size for cholestatic pruritus is anticipated to experience robust growth. It is projected to expand to $24.97 billion by 2029, with a compound annual growth rate (CAGR) of 5.3%. The growth during the forecast period is likely to be driven by factors such as the rise in the elderly population, the increasing instances of atopic dermatitis and urticaria, an upsurge in the geriatric population, a growing number of chronic kidney diseases, and a surge in conditions related to pruritus. Notable trends expected during this period would be the emergence of new treatment alternatives, collaborations with major firms for the research into cholestatic pruritus, advancements in treatment methods, expansion of healthcare facilities, and technological innovations.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp
What Are the Core Market Drivers Propelling Growth in the Cholestatic Pruritus Industry?
The escalating incidence of liver diseases is anticipated to fuel the expansion of the cholestatic pruritus market. Liver disorders span a wide variety of conditions impacting liver function, including infections, autoimmune diseases, genetic conditions, and harm from toxins, causing inflammation, scarring or liver failure. The rising frequency of liver ailments can be attributed to growing obesity, diabetes, alcohol consumption, infections from viral hepatitis, toxins, and environmental factors. Cholestatic pruritus plays a vital role in diagnosing and managing liver diseases, serving as a critical symptom signalling obstructed bile flow and often initiating further exploration and treatment of the underlying liver conditions. For instance, in July 2023, the Office for Health Improvement and Disparities, a UK-based governmental organization dedicated to addressing health disparities, reported a 22% increase in hospital admissions for liver disease in England in the year ended 2022, surging from 67,458 to 82,290. Given these factors, the escalating occurrence of liver diseases is set to stimulate the growth of the cholestatic pruritus market.
How Is the Cholestatic Pruritus Market Segmented?
The cholestatic pruritus market covered in this report is segmented –
1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types
2) By Treatment Type: Medications, Phototherapy, Other Treatment Types
3) By Route Of Administration: Oral, Topical, Injectable
4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare
Subsegments:
1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure
2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures
3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk
4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp
Which Regions Are Driving the Next Phase of the Cholestatic Pruritus Market Growth?
North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Cholestatic Pruritus Industry?
With a focus on pioneering innovative solutions, major corporations within the cholestatic pruritus market are developing oral solutions to effectively manage symptoms, elevate patient compliance, and provide targeted relief by tackling the root cause of bile salt accumulation and inflammation. Essentially an oral solution for cholestatic pruritus is a medicinal liquid designed to decrease bile acid accumulation and mitigate severe itchiness in cholestasis patients. For example, in March 2024, Mirum Pharmaceuticals Inc., a biopharmaceutical firm based in the U.S, attained approval from the U.S. Food and Drug Administration (FDA) for its oral solution, LIVMARLI (maralixibat), aimed at treating cholestatic pruritus in patients aged five and above who suffer from progressive familial intrahepatic cholestasis (PFIC). LIVMARLI, a once-daily oral ileal bile acid transporter inhibitor, holds a breakthrough therapy designation for PFIC type 2 and is expected to have a significant effect on patients with cholestatic pruritus associated with PFIC. This offers a much-needed treatment alternative for those affected by the rarest subtypes.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report
How Is the Cholestatic Pruritus Market Defined and What Are Its Core Parameters?
Cholestatic pruritus refers to severe itching caused by the buildup of bile acids in the skin, typically resulting from liver diseases that impair bile flow. This condition can significantly affect a patient’s quality of life and often requires targeted treatment to manage the discomfort and address the underlying liver dysfunction.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21140
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model